HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope
Journal Article
·
· Nature Communications
- Harvard Medical School, Boston, MA (United States)
- Duke Univ. Medical Center, Durham, NC (United States); Duke Human Vaccine Inst., Durham, NC (United States)
- Duke Human Vaccine Inst., Durham, NC (United States); Duke Univ. Medical Center, Durham, NC (United States)
- Sloan Kettering Institute, New York, NY (United States)
- Swarthmore College, PA (United States)
HIV-1 envelope (Env) mimetics are candidate components of prophylactic vaccines and potential therapeutics. Here we use a synthetic V3-glycopeptide (“Man9-V3”) for structural studies of an HIV Env third variable loop (V3)-glycan directed, broadly neutralizing antibody (bnAb) lineage (“DH270”), to visualize the epitope on Env and to study how affinity maturation of the lineage proceeded. Unlike many previous V3 mimetics, Man9-V3 encompasses two key features of the V3 region recognized by V3-glycan bnAbs—the conserved GDIR motif and the N332 glycan. In our structure of an antibody fragment of a lineage member, DH270.6, in complex with the V3 glycopeptide, the conformation of the antibody-bound glycopeptide conforms closely to that of the corresponding segment in an intact HIV-1 Env trimer. An additional structure identifies roles for two critical mutations in the development of breadth. The results suggest a strategy for use of a V3 glycopeptide as a vaccine immunogen.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States)
- Sponsoring Organization:
- Medical Scientist Training Program (MSTP); NIH; NIH-ORIP HEI; National Inst. of Allergy and Infectious Diseases; USDOE Office of Science (SC), Basic Energy Sciences (BES) (SC-22). Scientific User Facilities Division
- Grant/Contract Number:
- AC02-06CH11357
- OSTI ID:
- 1431358
- Journal Information:
- Nature Communications, Journal Name: Nature Communications Journal Issue: 1 Vol. 9; ISSN 2041-1723
- Publisher:
- Nature Publishing GroupCopyright Statement
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope
Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies
Journal Article
·
Tue Mar 27 20:00:00 EDT 2018
· Nature Communications
·
OSTI ID:1624084
Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies
Journal Article
·
Tue Mar 14 20:00:00 EDT 2017
· Science Translational Medicine
·
OSTI ID:1406204